Jianhong Zhu

107 Yanjiang West Road
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Development and Validation of a Rapid Benefit-Risk Assessment Index for Pediatric Off-Label Drug Use.

Development and Validation of a Rapid Benefit-Risk Assessment Index for Pediatric Off-Label Drug Use.

Journal: Journal of evidence-based medicine

Published: January 23, 2026

Safety profile of nivolumab-relatlimab in cancer patients: a living pharmacovigilance study of clinical trials and postmarketing data (version 1.0).

Safety profile of nivolumab-relatlimab in cancer patients: a living pharmacovigilance study of clinical trials and postmarketing data (version 1.0).

Journal: European journal of pharmacology

Published: April 10, 2025

Incidence and risk of treatment-related fatal adverse events in cancer patients treated with antibody conjugated drugs: a systematic review and meta-analysis of randomized controlled trials.

Incidence and risk of treatment-related fatal adverse events in cancer patients treated with antibody conjugated drugs: a systematic review and meta-analysis of randomized controlled trials.

Journal: Expert opinion on drug safety

Published: February 20, 2025

Cost-effectiveness analysis of immune checkpoint inhibitors as first-line therapy in advanced biliary tract cancer.

Cost-effectiveness analysis of immune checkpoint inhibitors as first-line therapy in advanced biliary tract cancer.

Journal: Immunotherapy

Published: September 11, 2024

Hemorrhage profile associated with immune checkpoint inhibitors: a systematic review and a real-world study based on the FAERS database.

Hemorrhage profile associated with immune checkpoint inhibitors: a systematic review and a real-world study based on the FAERS database.

Journal: Expert opinion on drug safety

Published: April 01, 2024

Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review.

Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review.

Journal: Expert opinion on drug safety

Published: February 16, 2023

Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study.

Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study.

Journal: Expert opinion on drug safety

Published: August 05, 2022

Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database.

Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database.

Journal: BMC nephrology

Published: June 18, 2022

Acute kidney injury associated with immune checkpoint inhibitors: A pharmacovigilance study.

Acute kidney injury associated with immune checkpoint inhibitors: A pharmacovigilance study.

Journal: International immunopharmacology

Published: May 08, 2022

Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis.

Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis.

Journal: Archives of gynecology and obstetrics

Published: July 19, 2021

Pulmonary tuberculosis associated with immune checkpoint inhibitors: a pharmacovigilance study.

Pulmonary tuberculosis associated with immune checkpoint inhibitors: a pharmacovigilance study.

Journal: Thorax

Published: May 03, 2021

Global research trends of drug-induced liver injury (DILI) in the past two decades: a bibliometric and visualized study.

Global research trends of drug-induced liver injury (DILI) in the past two decades: a bibliometric and visualized study.

Journal: Annals of palliative medicine

Published: April 23, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026